Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

D.A. Revicki, A.J.M. van den Eertwegh, P. Lorigan, C. Lebbe, G. Linette, C.H. Ottensmeier, S. Safikhani, M. Messina, A. Hoos, S. Wagner, S. Kotapati

Research output: Contribution to journalArticleAcademicpeer-review

51 Downloads (Pure)
Original languageUndefined/Unknown
Article number66
JournalHealth and Quality of Life Outcomes
Volume10
DOIs
Publication statusPublished - 2012

Cite this